Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Type I and III interferons enhance IL-10 receptor expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12p70 production.
Highlights from the 31st ECTRIMS congress - Barcelona 2015.
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.
Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: A population-based study.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Association between age at onset of multiple sclerosis and vitamin D level-related factors.
Available evidence and outcome of off-label use of rituximab in clinical practice.
Transanal irrigation for bowel symptoms in patients with multiple sclerosis.
Functional Homotopic Changes in Multiple Sclerosis with Resting-State Functional MR Imaging.
Multiple sclerosis databases: present and future.
Pathogenesis of Pediatric Multiple Sclerosis.
Robotic therapy: the tipping point.
Cohort Study Comparing the Berg Balance Scale and the Mini-BESTest in Ambulatory People With Multiple Sclerosis.
Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
Microglia and necroptosis: The culprits of neuronal cell death in multiple sclerosis.
Diffusion restriction of the optic nerve in patients with acute visual deficit.
Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study.
Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.
Prolonged and symptomatic bradycardia following a single dose of fingolimod.
Metric Optimization for Surface Analysis in the Laplace-Beltrami Embedding Space.
Association of smoking with risk of multiple sclerosis: a population-based study.
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
Innovating openly: researchers and patients turn to crowdsourcing to collaborate on clinical trials, drug discovery, and more.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Alternative Approaches: A Systematic Review of Non-Pharmacological Treatments for Non-Spastic and Non-Trigeminal Pain in Patients with Multiple Sclerosis.

Pages